These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 21677700)

  • 21. Placental Growth Factor Administration Abolishes Placental Ischemia-Induced Hypertension.
    Spradley FT; Tan AY; Joo WS; Daniels G; Kussie P; Karumanchi SA; Granger JP
    Hypertension; 2016 Apr; 67(4):740-7. PubMed ID: 26831193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin II type 1 receptor autoantibody (AT1-AA)-mediated pregnancy hypertension.
    Herse F; LaMarca B
    Am J Reprod Immunol; 2013 Apr; 69(4):413-8. PubMed ID: 23279165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low Soluble Fms-Like Tyrosine Kinase-1, Endoglin, and Endothelin-1 Levels in Women With Confirmed or Suspected Preeclampsia Using Proton Pump Inhibitors.
    Saleh L; Samantar R; Garrelds IM; van den Meiracker AH; Visser W; Danser AHJ
    Hypertension; 2017 Sep; 70(3):594-600. PubMed ID: 28716993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Agonistic autoantibodies to the angiotensin II type I receptor cause pathophysiologic characteristics of preeclampsia.
    LaMarca B; Parrish MR; Wallace K
    Gend Med; 2012 Jun; 9(3):139-46. PubMed ID: 22498426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy.
    Parrish MR; Murphy SR; Rutland S; Wallace K; Wenzel K; Wallukat G; Keiser S; Ray LF; Dechend R; Martin JN; Granger JP; LaMarca B
    Am J Hypertens; 2010 Aug; 23(8):911-6. PubMed ID: 20431529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin D Supplementation Prevents Placental Ischemia Induced Endothelial Dysfunction by Downregulating Placental Soluble FMS-Like Tyrosine Kinase-1.
    Ma SL; Tian XY; Wang YQ; Zhang HF; Zhang L
    DNA Cell Biol; 2017 Dec; 36(12):1134-1141. PubMed ID: 28981319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of angiotensin II type I receptor agonistic autoantibodies (AT1-AA) in preeclampsia.
    LaMarca B; Wallace K; Granger J
    Curr Opin Pharmacol; 2011 Apr; 11(2):175-9. PubMed ID: 21317038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of hypoxia and hypoxia-inducible factor-1alpha in preeclampsia pathogenesis.
    Tal R
    Biol Reprod; 2012 Jun; 87(6):134. PubMed ID: 23034156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of heme oxygenase-1 attenuates sFlt-1-induced hypertension in pregnant rats.
    George EM; Arany M; Cockrell K; Storm MV; Stec DE; Granger JP
    Am J Physiol Regul Integr Comp Physiol; 2011 Nov; 301(5):R1495-500. PubMed ID: 21865547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.
    Maynard SE; Min JY; Merchan J; Lim KH; Li J; Mondal S; Libermann TA; Morgan JP; Sellke FW; Stillman IE; Epstein FH; Sukhatme VP; Karumanchi SA
    J Clin Invest; 2003 Mar; 111(5):649-58. PubMed ID: 12618519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular mechanisms of preeclampsia.
    Mutter WP; Karumanchi SA
    Microvasc Res; 2008 Jan; 75(1):1-8. PubMed ID: 17553534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of new definitions of preeclampsia at term on identification of adverse maternal and perinatal outcomes.
    Lai J; Syngelaki A; Nicolaides KH; von Dadelszen P; Magee LA
    Am J Obstet Gynecol; 2021 May; 224(5):518.e1-518.e11. PubMed ID: 33166504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Causative Effects of Genetically Determined High Maternal/Fetal Endothelin-1 on Preeclampsia-Like Conditions in Mice.
    Li F; Kakoki M; Smid M; Boggess K; Wilder J; Hiller S; Bounajim C; Parnell SE; Sulik KK; Smithies O; Maeda-Smithies N
    Hypertension; 2018 May; 71(5):894-903. PubMed ID: 29610266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.
    Aggarwal PK; Chandel N; Jain V; Jha V
    J Hum Hypertens; 2012 Apr; 26(4):236-41. PubMed ID: 21451568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelin as a final common pathway in the pathophysiology of preeclampsia: therapeutic implications.
    George EM; Palei AC; Granger JP
    Curr Opin Nephrol Hypertens; 2012 Mar; 21(2):157-62. PubMed ID: 22257796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Excess LIGHT contributes to placental impairment, increased secretion of vasoactive factors, hypertension, and proteinuria in preeclampsia.
    Wang W; Parchim NF; Iriyama T; Luo R; Zhao C; Liu C; Irani RA; Zhang W; Ning C; Zhang Y; Blackwell SC; Chen L; Tao L; Hicks MJ; Kellems RE; Xia Y
    Hypertension; 2014 Mar; 63(3):595-606. PubMed ID: 24324043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
    Holme AM; Roland MC; Henriksen T; Michelsen TM
    Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Placental-specific sFLT-1: role in pre-eclamptic pathophysiology and its translational possibilities for clinical prediction and diagnosis.
    Palmer KR; Tong S; Kaitu'u-Lino TJ
    Mol Hum Reprod; 2017 Feb; 23(2):69-78. PubMed ID: 27986932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relation between circulating angiotensin II type 1 receptor agonistic autoantibodies and soluble fms-like tyrosine kinase 1 in the pathogenesis of preeclampsia.
    Stepan H; Faber R; Wessel N; Wallukat G; Schultheiss HP; Walther T
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2424-7. PubMed ID: 16569734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First trimester serum angiogenic and anti-angiogenic factors in women with chronic hypertension for the prediction of preeclampsia.
    Nzelu D; Biris D; Karampitsakos T; Nicolaides KK; Kametas NA
    Am J Obstet Gynecol; 2020 Apr; 222(4):374.e1-374.e9. PubMed ID: 31705883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.